Olema Pharmaceuticals names Jason O’Byrne CFO
OLMA•O’Byrne’s background
O’Byrne most recently served as executive vice president and CFO at Vir Biotechnology, overseeing finance, investor relations, and information technology.
He previously was CFO at Caribou Biosciences, leading capital markets work including its IPO.
Earlier roles included senior vice president of finance at Audentes Therapeutics, supporting integration of its USD 3 billion acquisition by Astellas.
Olema names new chief financial officer
Olema Pharmaceuticals named Jason O’Byrne chief financial officer as it prepares for pivotal OPERA-01 data and a potential first commercial launch.
